Nonhuman primates are relevant models for research in hematology, immunology and virology

European Cytokine Network

Volumn 16, Issue 2, 2005, Pages 104-116

  Herodin F ^a   Thullier, P ^a   Garin, D ^a   Drouet, M ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

AIDS; Cytokines; Hematopoiesis; Immunology; Nonhuman primate model; Stem cell; Vaccine; Virology

Indexed keywords

CYTOKINE; GALIXIMAB; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 7; LEUKOCYTE ANTIGEN; LIVE VACCINE; MONOCLONAL ANTIBODY; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNE DISEASE; BABOON; BONE MARROW SUPPRESSION; CELL THERAPY; CHEMOTHERAPY; CLINICAL TRIAL; DRUG RESEARCH; EXPERIMENTAL MODEL; GENE THERAPY; HEMATOLOGY; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOTHERAPY; IN VITRO STUDY; MEDICAL RESEARCH; MONKEY; NONHUMAN; PRACTICE GUIDELINE; PRIMATE; PSORIASIS; REVIEW; RHESUS MONKEY; RHEUMATOID ARTHRITIS; UNSPECIFIED SIDE EFFECT; VACCINATION; VIROLOGY; VIRUS INFECTION; WHOLE BODY RADIATION; ANIMAL; ANIMAL MODEL;

PAPIO; PRIMATES;

ALLERGY AND IMMUNOLOGY; ANIMALS; HEMATOLOGY; MODELS, ANIMAL; PRIMATES; VIROLOGY;

EID: 32444445454     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (131)

1. Sablinski T, Emery DW, Monroy R, et al. Long-term discordant xenogeneic (porcine-to-primate) BM engraftment in a monkey treated with porcine-specific growth factors. Transplantation 1999; 67: 972.
2. Harker LA, Marzec UM, Novembre F, et al. Treatment of thrombocytopenia in chimpanzees infected with HIV by pegylated recombinant human MGDF. Blood 1998; 91: 4427.
3. Wiener AS, Socha WW, Moor-Jankowski J. Homologues of the human ABO blood groups in apes and monkeys. Haematologia 1974; 8: 195.
4. Prilliman K, Lawlor D, Ellexson M, et al. Characterization of baboon class I major histocompatibility molecules. Transplantation 1996; 61: 989.
5. Gomes I, Sharma TT, Mahmud N, et al. Highly abundant genes in the transcriptosome of human and baboon CD34 antigen-positive BM cells. Blood 2001; 98: 93.
6. Villinger F, Brar SS, Mayne A, Chikkala N, Ansari AA. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J Immunol 1995; 155: 3946.
7. Niblack GD, Gengozian N. T and B lymphocytes in the marmoset: a natural haemopoietic chimera. Clin Exp Immunol 1976; 23: 536.
8. Haig D. What is a marmoset? Am J Primatol 1999; 49: 285.
9. Norol F, Drouet M, Debili N, Vainchenker W, Hérodin F. Ex vivo expanded mobilized PB CD34+ cells accelerate hematologic recovery in a baboon model of autologous transplantation. Br J Haematol 2000; 109: 162.
10. Hillyer CD, Swenson RB, Hart KK, Lackey DA, Winton EF. PB stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model. Exp Hematol 1993; 21: 1455.
11. Mestries JC, Kruithof EKO, Gascon MP, Hérodin F, Agay D, Ythier A. In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human IL-6 in baboons. Eur Cytokine Netw 1994; 5: 275.
12. Ozwara H, Niphuis H, Buijs L, et al. Flow cytometry analysis on reactivity of human T lymphocyte-specific and cytokine-receptor-specific antibodies with PB mononuclear cells of chimpanzee, rhesus macaque and squirrel monkey. J Med Primatol 1997; 26: 164.
13. Van Gils FCJM, Budel L, Burger H, Van Leen RW, Löwenberg B, Wagemaker G. IL-3 receptors on rhesus monkey BM cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF. Exp Hematol 1994; 22: 248.
14. Berenson RJ, Andrews RG, Bensinger WI, et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 1988; 81: 951.
15. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133: 157.
16. Storb R, Graham TC, Epstein RB, Sale GE, Thomas ED. Demonstration of hemopoietic stem cells in the PB of baboons by cross circulation. Blood 1977; 50: 537.
17. Mahmud N, Devine SM, Weller KP, Parmar S, Sturgeon C, Nelson MC, et al. The relative quiescence of hematopoietic stem cells in nonhuman primates. Blood 2001; 97: 3061.
18. Andrews RG, Bryant EM, Bartelmez SH, Muirhead DY, Knitter GH, Bensinger W, et al. CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 1992; 80: 1693.
19. De-Jong MO, Westerman Y, Wagemaker G, Wognum AW. Coexpression of Kit and the receptors for EPO, IL-6 and GM-CSF on hemopoietic cells. Stem Cells 1997; 15: 275.
20. Sopper S, Stahl-Hennig C, Demuth M, Johnston ICD, Dörries R, ter Meulen V. Lymphocyte subsets and expression of differentiation markers in blood and lymphoid organs of rhesus monkeys. Cytometry 1997; 29: 351.
21. Drouet M, Mathieu J, Grenier N, Multon E, Sotto JJ, Hérodin F. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, Flt-3 Ligand, TPO and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells 1999; 17: 273.
22. Devine SM, Bartholomew AM, Mahmud N, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244.
23. Coates PT, Barratt-Boyes SM, Zhang L, et al. Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with FLT3 ligand. Blood 2003; 102: 2513.
24. Michelson AD, Barnard MR, Hetchman HB, MacGregor H, Connolly RJ, Loscalzo J, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877.
25. Kotze HF, Lotter MG, Badenhorst PN, Heyns AD. Kinetics of In-111-platelets in the baboon: II. In vitro distribution and sites of sequestration. Thromb Haemost 1985; 53: 408.
26. Eves EM, Heller P, DeSimone J. Differences in burst morphology among baboon species. Exp Hematol 1989; 17: 73.
27. Fisher JW, Koury S, Ducey T, Mendel S. Erythropoietin production by interstitial cells of hypoxic kidneys. Br J Haematol 1996; 95: 27.
28. Schmidt M, Zickler P, Hoffmann G, Haas S, Wissler M, Muessig A, et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood 2002; 100: 2737.
29. Berg SL, Reid J, Godwin K, Murry DJ, Poplack DG, Balis FM, et al. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model. J Pediatr Hematol Oncol 1999; 21: 26.
30. Laukkanen MO, Kuramoto K, Calmels B, Takatoku M, von Kalle C, Donahue RE, Dunbar CE. Low dose TBI causes clonal fluctuation of primate hematopoietic stem cell and progenitor cells. Blood 2005; 105: 1010.
31. Farese AM, Hunt P, Boone T, MacVittie TJ. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995; 86: 54.
32. Kuramoto K, Follmann DA, Hematti P, et al. Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates. Blood 2004; 103: 4070.
33. Slungaard A, Fernandez JA, Griffin JH, Key NS, Long JR, Piegors DJ, et al. Platelet factor 4 enhances generation of activated protein C in vitro and in vivo. Blood 2003; 102: 146.
34. Gruber A, Hanson R. Factor XI-dependence of surface-and tissue factor-initiated thrombus propagation in primates. Blood 2003; 102: 953.
35. Hérodin F, Mestries JC, Janodet D, Martin S, Mathieu J, Gascon MP, et al. Recombinant glycosylated human interleukin-6 accelerates PB platelet count recovery in radiation-induced BM depression in baboons. Blood 1992; 80: 688.
36. Bertho JM, Demarquay C, Frick J, et al. Level of Flt3-ligand in plasma: a new bio-indicator for radiation-induced aplasia? Int J Radiat Biol 2001; 77: 103.
37. Kennedy AD, Solga MD, Schuman TA, et al. An anti-CD3(i) mAb enhances complement activation, C3bb(i) deposition, and killing of CD20+ cells by rituximab. Blood 2003; 101: 1071.
38. Rubenstein JL, Combs DC, Rosenberg J, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeneingeal compartment. Blood 2003; 101: 466.
39. Adamson RH, McIntire KR, Sieber SM, Correa P, Dalgard DW. Nonhuman primate models for lymphoma, leukemia, and other neoplasms. Bibl Haematol 1975; 40: 723.
40. Dorssers LC, Burger H, Wagemaker G, de Koning JP. Identification of functional domains of interleukin-3 by construction of primate interspecies chimera. Growth Factors 1994; 11: 93.
41. Wen D, Boissel JP, Tracy TE, Gruninger RH, Mulcahy LS, Czelusniak J, et al. Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 1993; 82: 1507.
42. Donahue RE, Wang EA, Stone DK, Wong GG, Sehgal PK, Nathan DG, et al. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986; 321: 872.
43. Weite K, Bonilla MA, Gillio AP, et al. Recombinant human G-CSF. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 1987; 165: 941.
44. Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ. Recovery from severe hematopoietic suppression using recombinant human GM-CSF. Exp Hematol 1988; 16: 344.
45. Gillio AP, Gasparetto C, Laver J, Abboud M, Bonilla MA, Garnick MB, et al. Effects of IL-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates. J Clin Invest 1990; 85: 1560.
46. Scherman FJ, Bree AG, Kaviani MD, Nagel SL, Donnelly LH, Mason LE, et al. Thrombopoietic activity of recombinant human IL-11 in normal and myelosuppressed nonhuman primates. Stem Cells 1996; 14: 517.
47. Farese AM, Hunt P, Grab LB, MacVittie TJ. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest 1996; 97: 2145.
48. MacVitttie TJ, Farese AM, Hérodin F, Grab LB, Baum C, McKearn JP. Combination therapy for radiation-induced BM aplasia in nonhuman primates using synthokine SC-55494 and rhG-CSF. Blood 1996; 87: 4129.
49. Williams DE, Dunn JT, Park LS, Frieden EA, Seiler FR, Farese AM, et al. IL-3 fusion protein promotes neutrophil and platelet recovery in sublethally irradiated rhesus monkeys. Biotechnol Therapeut 1993; 4: 17.
50. Mac Vittie TJ, Farese AM, Smith WG, Baum CM, Burton E, McKearn JP. Myelopoeitin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression. Blood 2000; 95: 837.
51. Drouet M, Mourcin F, Grenier N, et al. Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long term follow-up of hematopoiesis. Blood 2004; 103: 878.
52. Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G. The efficacy of a single-dose administration of thrombopoietin with coadministration of either granulocyte macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys. Blood 1997; 90: 2565.
53. Andrews RG, Briddell RA, Hill R, Gough M, McNiece IK. Engraftment of primates with G-CSF mobilized PB CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia. Stem Cells 1999; 17: 210.
54. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK. Rapid engraftment by PB progenitor cells mobilized by recombinant human SCF and G-CSF in nonhuman primates. Blood 1995; 85: 15.
55. Laterveer L, Lindley IJD, Heemskerk D, Camps J, Pauwels E, Willemze R, et al. Rapid mobilization of hematopoietic progenitor cells in rhesus-monkeys by a single intravenous injection of interleukin-8. Blood 1996; 87: 781.
56. Vétillard J, Drouet M, Neildez-Nguyen TMA, Mestries JC, Mathieu J, Thierry D, et al. Interleukin-8 acts as a strong PB granulocyte recruiting agent rather than as a hematopoietic progenitor cell mobilizing factor. J Hematother Stem Cell Res 1999; 8: 365.
57. Papayannopoulou T, Nakamoto B, Andrews RG, Lyman SD, Lee MY. In vivo effects of flt3/flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with G-CSF. Blood 1997; 90: 620.
58. 4integrin. Proc Natl Acad Sci USA 1993; 90: 9374.
59. King AG, Horowitz D, Dillon SB, Levin R, Farese AM, Mac Vittie TJ, et al. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRO-β. Blood 2001; 97: 1534.
60. Storb R, Raff RF, Appelbaum FR, et al. Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts. Blood 1994; 83: 3384.
61. Hartong SCC, Neelis KJ, Visser TP, Wagemaker G. Lack of efficacy of TPO and GM-CSF after total body irradiation and autologous BM transplantation in rhesus monkeys. Exp Hematol 2000; 28: 753.
62. Monroy RL, Skelly RR, MacVittie TJ, Davis TA, Sauber JJ, Clark SC, et al. The effect of recombinant GM-CSF on the recovery of monkeys transplanted with autologous BM. Blood 1987; 70: 1696.
63. MacVittie TJ, Farese AM, Davies TA, Lind LB, McKearn JP. Myelopoeitin a chimeric agonist of human IL-3 and G-CSF receptors, mobilizes CD34+ cells that rapidly engraft X-irradiated nonhuman primates. Exp Hematol 1999; 27: 1557.
64. Brandt JE, Bartholomew AM, Fortman JD, et al. Ex vivo expansion of autologous bone marow CD34+ cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood 1999; 94: 106.
65. Drouet M, Hérodin F, Norol F, Mourcin F, Mayol JF. Cell cycle activation of PB stem and progenitor cells expanded ex vivo with SCF, FLT-3 ligand, TPO and IL-3 results in accelerated granulocyte recovery in a baboon model of autologous transplantation but G0/G1 and S/G2/M graft cell content does not correlate with transplantability. Stem Cells 2001; 19: 436.
66. + cells. Br J Haematol 2002; 117: 924.
67. Drouet M, Mourcin F, Grenier N, Leroux V, Mayol JF, Lataillade JJ, et al. Mesenchymal stem cells enhance platelet recovery in lethally irradiated baboons given low size ex vivo expanded grafts. Exp Hematol 2003; 31(suppl. 1): 180.
68. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolonge skin graft survival in vivo. Ex hematol 2002; 30: 42.
69. Brown JM, Weissman IL. Progress and prospects in hematopoietic stem cell expansion and transplantation. Exp Hematol 2004; 32: 693.
70. Amsellem S, Pflumio F, Bardinet D, et al. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HoxB4 homeoprotein. Nat Med 2003; 9: 1423.
71. Harrison MR, Slotnick RN, Crombleholme TM, Golbus MS, Tarantal AF, Zanjani ED. In utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet 1989; 8677: 1425.
72. Shields LE, Gaur LK, Gough M, Potter J, Sieverkropp A, Andrews RG. In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells 2003; 21: 304.
73. Mychaliska GB, Rice HE, Tarantal AF, et al. In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplantation in monkeys. J Pediatr Surg 1997; 32: 976.
74. Cosimi AB, Sachs DH. Mixed chimerism and transplantation tolerance. Transplantation 2004; 77: 943.
75. Hanazono Y, Terao K, Ozawa K. Gene tranfer into nonhuman primate hematopoietic stem cells: implications for gene therapy. Stem Cells 2001; 19: 12.
76. Hanawa H, Hematti P, Keyvanfar K, et al. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vetor system. Blood 2004; 103: 4062.
77. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 1996; 272: 263.
78. Wu T, Kim HJ, Sellers SE, et al. Prolonged high level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods. Mol Ther 2000; 1: 285.
79. Andrews RG, Peterson LJ, Morris J, Potter J, Heyward S, Gough M, et al. Differential engraftment of genetically modified CD34+ and CD34- hematopoietic cell subsets in lethally irradiated baboons. Exp Hematol 2000; 28: 508.
80. Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, et al. Ex vivo expansion of genetically marked rhesus PB progenitor cells results in diminished long-term repopulating ability. Blood 1998; 92: 1131.
81. Morris JC, Conerly M, Thomasson B, Storek Y, Riddell SR, Kiem HP. Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning. Blood 2004; 103: 492.
82. Chenuaud P, Larchet T, Rabinowitz JE, et al. Autoimmune anemia in macaques following erythropoietin gene therapy. Blood 2004; 103: 3303.
83. Donahue RE, Wersto RP, Allay JA, et al. High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized PB CD34+ cells. Blood 2000; 95: 445.
84. Rozensweig M, MacVittie TJ, Harper D. Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood 1999; 94: 2271.
85. Winkler A, Kiem HP, Shields LE, Sun QH, Andrews RG. Gene transfer into fetal baboon hematopoietic progenitor cells. Hum Gene Ther 1999; 10: 667.
86. De Revel T, Becard N, Sorg T, Thiebot H, Methali M, Dormont D, Le Grand R. Injection intramédullaire d'adénovirus recombinant codant pour L'IL-1α chez le macaque cynomolgus: un modèle de stimulation de L'hématopoïèse par transfert in situ de gènes de cytokines. Congrès de la SFGM, Marseille, 2000.
87. Horn PA, Thomasson BM, Wood BL, Andrews RG, Morris JC, Kiem HP. Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates. Blood 2003; 102: 4329.
88. Nakatsuji N, Suemori H. Embryonic stem cell lines of nonhuman primates. The Scientific World J 2002; 2: 1762.
89. Wolf DP, Kuo HC, Pau KY, Lester L. Progress with nonhuman primate embryonic stem cells. Biol Reprod 2004; 71: 1766.
90. Vrana KE, Hipp JD, Goss AM, et al. Nonhuman primate parthenogenetic stem cell. Proc Natl Acad Sci USA 2003; 100: 11911.
91. Honig GR, Lee F, Lu SJ, Vida L. Hematopoietic differentiation of rhesus monkey embryonic stem cells. Blood Cells Mol Dis 2004; 3: 5.
92. Umeda K, Heike T, Yoshimoto M, et al. Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro. Development 2004; 131: 1869.
93. Kaufman DS, Lewis RL, Hanson ET, Auerbach R, Plendl J, Thomson JA. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood 2004; 103: 1325.
94. Norol F, Merlet P, Isnard R, et al. Influence of mobilized stem cells on myocardial infarct repair in a non human primate model. Blood 2003; 102: 4361.
95. Gao C, Kang EM, Kuramoto K, et al. Retrovirally transduced muscle-derived cells contribute to hematopoiesis at very low level in the nonhuman primate model. Mol Ther 2003; 8: 974.
96. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic injection into nonhuman primates. Blood 2003; 101: 2999.
97. Gorman SD, Clark MR. Humanisation of monoclonal antibodies for therapy. Semin Immunol 1990; 2: 457.
98. Wild MA, Xin H, Maruyama T, et al. Human antibodies from immunized donors are protective against anthrax toxin in vivo. Nat Biotechnol 2003; 21: 1305.
99. Lewis AP, Barber KA, Cooper HJ, Sims MJ, Worden J, Crowe JS, et al. Cloning and sequence analysis of kappa and gamma cynomolgus monkey immunoglobulin cDNAs. Dev Comp Immunol 1993; 17: 549.
100. Newman R, Alberts J, Anderson D, Carner K, Heard C, Norton F, et al. "Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. Biotechnology (N Y) 1992; 10: 1455.
101. Gottlieb AB, Kang S, Linden KG, et al. Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis. Clin Immunol 2004; 111: 28.
102. Bugelski PJ, Herzyk DJ, Rehm S, et al. Preclinical development of keliximab, a primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies. Hum Exp Toxicol 2000; 19: 230.
103. Glamann J, Burton DR, Parren PN, Ditzel HJ, Kent KA, Arnold C, et al. Simian immunodeficiency virus (SIV) envelope-specific fabs with high-level homologous neutralizing activity: recovery from a long-term non-progressor SIV-infected macaque. J Virol 1998; 72: 585.
104. Andris-Wihopf J. Generation of antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequences. In: Barbas III CF, et al., eds. Phage Display: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 2001.
105. Chassagne S, Laffly E, Drouet E, Hérodin F, Lefranc MP, Thullier P. A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library. Mol Immunol 2004; 41: 539.
106. Lefranc MP. IMGT-ONTOLOGY and IMGT databases, tools and web ressources for immunogenetics and immunoinformatics. Mol Immunol 2004; 40: 647.
107. Storek J, Gillepsy T, Lu H, et al. Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood 2003; 101: 4209.
108. Fry TJ, Moniuszko M, Creekmore S, et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003; 101: 2294.
109. Carlsson HE, Schapiro SJ, Farah I, Hau J. Use of primates in research: a global overview. Am J Primatol 2004; 63: 225.
110. Stittelaar KJ, Vos HV, van Amerongen G, Kersten GFA, Osterhaux ADME, de Swart RL. Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates. Vaccine 2002; 21: 155.
111. Rey M, Robin Y, Camain R, Diop Mar I, Oudart JL, Gangue Y, et al. Epidemiological and clinical aspects of 248 encephalitis following yellow fever vaccination. Bull Soc Med Afr Noire Lang Fr 1966; 11: 560.
112. Kitchener S. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX. Vaccine 2004; 22: 2103.
113. Marchevsky RS, Freire MS, Coutinho ES, Galler R. Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys. Virology 2003; 316: 55.
114. European pharmacopoeia, 4th Edition. 2002.
115. WHO. Requirements for yellow fever vaccine. WHO technical report series 1998; 872: 30.
116. Staprans S, Staprans S. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines. Expert Rev Vaccines 2004; 3(Suppl 1): S5.
117. Lifson JD, Rossio JL, Piatak Jr. M, et al. Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins. AIDS Res Hum Retroviruses 2004; 20: 772.
118. Ramsburg E, Rose NF, Marx PA, et al. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol. J Virol 2004; 78: 3930.
119. Hirsch VM, Lifson JD. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol 2000; 49: 437.
120. Thiebot H, Vaslin B, Derdouch S, et al. Impact of bone marrow hematopoiesis failure on T-cell generation during pathogenic simian immunodeficiency virus infection in macaques. Blood 2005; 105: 2403.
121. Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000; 74: 6087.
122. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body components TRIM5a restrict HIV-1 infection in old world monkeys. Nature 2004; 427: 848.
123. Harris RS, Liddament MT. Retroviral restrictions by APOBEC proteins. Nat Rev Immunol 2004; 4: 868.
124. Muller MC, Barre-Sinoussi F. SIVagm: genetic and biological features associated with replication. Front Biosci 2003; 8: 1170.
125. Keckesova Z, Ylinen LMJ, Towers GJ. The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factors activities. Proc Natl Acad Sci USA 2004; 101: 10780.
126. Sawyer SL, Wu LI, Emerman M, Malik HS. Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci USA 2005; 102: 2832.
127. Yap MW, Nisole S, Stoye JP. A single amino acid change in the SPRY domain of human TRIM5α leads to HIV-1 restriction. Curr Biol 2005; 15: 73.
128. Jahrling PB, Zaucha GM, Huggins JW. Countermeasures to the re-emergence of smallpox virus as an agent of bioterrorism. In: Scheld WM, Craig WA, Hughes JM, eds. Emerging infections 4. Washington D.C: ASM press, 2000: 187.
129. EMEA committee for proprietary medicinal products. Note for guidance on the development of vaccinia virus-based vaccines against smallpox. EMEA report 2002: 1.
130. Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkey-pox. Nature 2004; 28: 182.
131. Lucciani P. Les primates non humains en recherche biomédicale. Primatologie 1998; 1: 285.